Vaccines Containing Non-Live Antigenic Vectors

STABILIZED HBc CHIMER PARTICLES AS THERAPEUTIC VACCINE FOR CHRONIC HEPATITIS

COMPOSITIONS AND METHODS FOR CHITOSAN ENHANCED IMMUNE RESPONSE

Immunostimulatory oligonucleotides

TRANSDERMAL IMMUNE PREPARATION, METHOD FOR PRODUCTION OF THE SAME, AND TRANSDERMAL IMMUNIZATION METHOD USING THE SAME

IMMUNOGENIC MOLECULES

POLYMER PARTICLES BASED VACCINE

Hepatitis C virus codon optimized non-structural NS3/4A fusion gene

Packaging of Immunostimulatory Substances Into Virus-Like Particles: Method of Preparation and Use

Method to enhance an immune response of nucleic acid vaccination

Detection and use of antiviral resistance mutations

VACCINE

Optimized multi-epitope constructs and uses thereof

Enhancing of hepatitis B virus vaccine and its gene

Method and System for Optimizing Minigenes and Peptides Encoded Thereby

Inactivated polio vaccines

Split-core-particles for the presentation of foreign molecules, especially for vaccine applications, and method for their production

Vaccine

Multiple vaccination including serogroup C meningococcus

COMPOSITIONS AND METHODS FOR ELICITING AN IMMUNE RESPONSE TO ESCAPE MUTANTS OF TARGETED THERAPIES

Immunogenic compositions comprising nanoemulsion and hepatitis B virus immunogen and methods of using the same

STABILIZATION OF AQUEOUS COMPOSITIONS OF PROTEINS WITH DISPLACEMENT BUFFERS

Processes for treating subjects carrying viral infectious agent

Chimeric immunomodulatory compounds and methods of using the same-II

NANOEMULSION ADJUVANTS

Enhancement of an immune response by administration of a cationic lipid-DNA complex (CLDC)

Immunogenic composition

VIRUS LIKE PARTICLES

VACCINE DELIVERY SYSTEM

IMMUNOGEN PLATFORM

Combination vaccines with whole cell pertussis antigen

MODIFIED CpG OLIGODEOXYNUCLEOTIDE WITH IMPROVED IMMUNOREGULATORY FUNCTION

METHOD FOR ENHANCING THE EFFICACY OF ANTIGEN SPECIFIC TUMOR IMMUNOTHERAPY

Manufacturing Method of Combined Vaccine

Expressing hepatitis B virus surface antigen for vaccine preparation

Powerful vaccine composition comprising lipopeptide and poly I:C as an adjuvant

Manufacture of Vaccines That Contain Both Hepatitis B Virus Surface Antigen and Surfactant

METHOD FOR TREATING TUMOR USING IRRADIATED TUMOR CELL EXPRESSING HUMAN HEPATITIS B SURFACE ANTIGEN AND A PHARMACEUTICAL COMPOSITION COMPRISING THE TUMOR CELL

Immunogenic composition

Stable vaccine formulation

Purification of HBV antigens for use in vaccines

Method for Obtaining Antigenic Aggregates and the Use Thereof in Formulations

Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response

Nucleotide vector, composition containing such vector, and vaccine for immunization against hepatitis

Vaccines with enhanced immune response and methods for their preparation

Virosome particles comprising antigens from influenza virus and hepatitis b virus

Vaccines with enhanced immune response and methods for their preparation

Immunomodulator Compounds as Vaccine Enhancers

Immunogen platform

Methods for generating immune response using cationic-liposome-mediated nucleic acid delivery

Immunogenic composition

Modified Viral Particles with Immunogenic Properties and Reduced Lipid Content Useful for Treating and Preventing Infectious Diseases

Conjugate Vaccines

Compositions and methods for enhancing immune responses mediated by antigen-presenting cells

Vaccine Compositions Comprising a Saponin Adjuvant

Modified Viral Particles with Immunogenic Properties and Reduced Lipid Content Useful for Treating and Preventing Infectious Diseases

Compositions for inducing an immune response against hepatitis B

Hiv Gp-41-Membrane Proximal Region Arrayed On Hepatitis B Surface Antigen Particles as Novel Antigens

HLA binding motifs and peptides and their uses

STABLE POWDER FORMULATIONS OF ALUM-ADSORBED VACCINES

Adjuvant systems and vaccines

Method of Treating and Preventing Infectious Diseases via Creation of a Modified Viral Particle with Immunogenic Properties

Method of Treating and Preventing Infectious Diseases via Creation of a Modified Viral Particle with Immunogenic Properties

Rodent hepatitis B virus core proteins as vaccine platforms and methods of use thereof

Hepatitis C virus codon optimized non-structural NS3/4A fusion gene

Immunogenic composition

Immunogenic composition

Chimeric immunomodulatory compounds and methods of using the same

Recombinant HBsAg virus-like particles containing polyepitopes of interest, their production and use

OIL IN WATER EMULSIONS CONTAINING SAPONINS

Methods of inducing mucosal immunity

Hepadna virus core proteins as vaccine platforms and methods of use thereof

Vaccine Composition Against Hepatitis C Virus

Compositions and methods for identifying antigens which elicit an immune response

Recombinant plasmid and method for expressing hepatitis B viral antigens and virions in vivo

Methods to bypass CD4+ cells in the induction of an immune response

Novel Composition

Hybrid or chimeric polynucleotides, proteins, and compositions comprising hepatitis B virus sequences

Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response

VACCINE COMPOSITION

Liquids Containing Suspended Glass Particles

HBV core antigen particles with multiple immunogenic components attached via peptide ligands

Pharmaceutical Compositions for Therapeutic Use

IRIDOID GLYCOSIDE COMPOSITION

Method of treating and preventing infectious diseases

Vaccine Comprising a Polysaccharide Antigen-Carrier Protein Conjugate and Free Carrier Protein

HLA binding motifs and peptides and their uses

Chimeric immunomodulatory compounds and methods of using the same—IV

Optimized multi-epitope constructs and uses thereof

Nucleic acid vaccine compositions having a mammalian CD80/CD86 gene promoter driving antigen expression

Use of alum and a th1 immune response inducing adjuvant for enhancing immune responses

Influenza immunogen and vaccine

Vaccine-induced hepatitis B viral strain and uses thereof

Method

Methods for genetic immunization

Stabilized immunogenic HBc chimer particles

Minimal promoters and uses thereof

Methods and compositions for inducing antigen-specific immune responses

Composition

Vaccines

HBsAg-BCG combined vaccine for intracutaneous injection and preparation method thereof

Packaging of immunostimulatory oligonucleotides into virus-like particles: method of preparation and use

Packaged virus-like particles

Vaccines

Composition for the prophylaxis and treatment of HBV infections and HBV-mediated diseases

Oral DNA composition for hepatitis B virus chronic infection

Compositions and methods for delivery of genetic material

Immunostimulating polyphosphazene compounds

Hepatitis C virus codon optimized non-structural NS3/4A fusion gene

Vaccines containing ribavirin and methods of use thereof

Purification of HBV antigens for use in vaccines

Composition for vaccination

Regulated bacterial lysis for gene vaccine vector delivery and antigen release

Herpes viruses for immune modulation

Viruses and virus-like particles for multiple antigen and target display

Polyanionic polymer adjuvants for haemophilus influenzae B saccharide vaccines

Combination gene delivery vehicles

Influenza immunogen and vaccine

Adenovirus vectors for immunotherapy

Stabilization of alum-adjuvanted immunologically active agents

Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus

Antigen library immunization

Methods for tailoring the immune response to an antigen or immunogen

Novel therapeutic processes for treating infectious agents using same epitope specific antigens, and useful compositions therefor

Adjuvant

Novel therapeutic processes for treating cancer with trained or adopted immune cells, and useful compositions therefor

Novel therapeutic processes for treating cancer with specific antigens

Novel therapeutic processes for treating infectious agents by training or adoptive transfer of immune cells, and useful compositions therefor

Novel therapeutic processes for enhancing immunized states of vaccinated subjects

Vaccines expressed in plants

Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus

Nucleic acid vaccine compositions having a mammalian CD80/CD86 gene promoter driving antigen expression

Method to enhance an immune response of nucleic acid vaccination

Vaccines containing a saponin and a sterol

Combination therapies with L-FMAU for the treatment of hepatitis B virus infection

Modified CpG oligodeoxynucleotide with improved immunoregulatory function

Hepatitis B virus treatment

Therapeutic processes and useful compositions therefor

Novel therapeutic vaccination processes, and useful compositions therefor

Combined dna/protein vaccine compositions

Vaccine comprising a polysaccharide antigen - carrier protein conjugate and free carrier protein

Hepatitis C virus codon optimized non-structural NS3/4A fusion gene

Vaccine against HBV and HPV

Immunogenic compositions containing microparticles comprising adsorbed toxoid and polysaccharide-containing antigens

Novel therapeutic processes for establishing or enhancing an immunized state, and compositions useful therefor

Hepatitis A vaccines

Ultrasound assisted transdermal vaccine delivery method and system

Methods and composition for delivering nucleic acids and/or proteins to the intestinal mucosa

Human hepatoma lines, methods for obtaining same and uses thereof

Methods for particle-assisted polynucleotide immunization using a pulsed electric field

Method of treating viral infections

Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant

Nucleotide vector vaccine for immunization against hepatitis

Vectors and methods for immunization or therapeutic protocols

Modified viral particles with immunogenic properties and reduced lipid content

Human hepatitis B virus core proteins as vaccine platforms and methods of use thereof

Rodent hepatitis B virus core proteins as vaccine platforms and methods of use thereof

Hepatitis b virus surface antigen as a mucosal immunostimulator and the resulting formulations

Vaccines with enhanced immune response and methods for their preparation